Clinical predictors and microbiology of ventilator-associated pneumonia in the intensive care unit: a retrospective analysis in six Italian hospitals von Delle Rose, D., Pezzotti, P., Fortunato, E., Sordillo, P., Gini, S., Boros, S., Meledandri, M., Gallo, M. T., Prignano, G., Caccese, R., D’Ambrosio, M., Citterio, G., Rocco, M., Leonardis, F., Natoli, S., Fontana, C., Favaro, M., Celeste, M. G., Franci, T., Testore, G. P., Andreoni, M., Sarmati, L.

Volltext

Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients von Lorusso, D, Scambia, G, Amadio, G, di Legge, A, Pietragalla, A, De Vincenzo, R, Masciullo, V, Di Stefano, M, Mangili, G, Citterio, G, Mantori, M, Lambiase, A, Bordignon, C

Volltext

Phase Ib study of NGR-hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours von Gregorc, V, Santoro, A, Bennicelli, E, Punt, C J A, Citterio, G, Timmer-Bonte, J N H, Caligaris Cappio, F, Lambiase, A, Bordignon, C, van Herpen, C M L

Volltext

An electrochemical impedance study of bare and anodized AZ31 Mg alloy in dilute Harrison solution von Citterio, G., Trasatti, S.P., Trueba, M., Bestetti, M., Da Forno, A.

Volltext

Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma von Santoro, A, Pressiani, T, Citterio, G, Rossoni, G, Donadoni, G, Pozzi, F, Rimassa, L, Personeni, N, Bozzarelli, S, Rossoni, G, Colombi, S, De Braud, F G, Caligaris-Cappio, F, Lambiase, A, Bordignon, C

Volltext

9014 POSTER DISCUSSION Randomized Phase II Trial of NGR-hTNF and Chemotherapy in Chemo-naive Patients With Non-small Cell Lung Cancer (NSCLC) -Preliminary Results von Gregore, V, Zilembo, N, Grossi, F, Rossoni, G, Pietrantonio, F, Rijavec, E, Citterio, G, Platania, M, Lambiase, A, Bordignon, C

Volltext

In vivo administration of GM-CSF promotes the clearance of apoptotic cells: effects on monocytes and polymorphonuclear leukocytes von Galati, Giacomo, Rovere, Patrizia, Citterio, Giovanni, Bondanza, Attilio, Scaglietti, Ugo, Bucci, Eraldo, Heltai, Silvia, Fascio, Umberto, Rugarli, Claudio, Manfredi, Angelo A.

Volltext

Patient-reported outcomes (PROs) and impact of lactate dehydrogenase (LDH) levels on outcomes in a phase 3 trial (NGR015) with best investigator choice (BIC) plus or minus NGR-hTNF... von Gregorc, V., Bulotta, A., Viganò, M.G., Citterio, G., Petrella, G., Brioschi, E., Ducceschi, M., Gianni, L., Colombi, S., Rossoni, G., Salini, G., Savia, V., Lambiase, A., Bordignon, C.

Volltext

6617 Phase II study of NGR-hTNF, a selective vascular targeting agent (VTA), in previously treated patients (pts) with advanced hepatocellular carcinoma (HCC) von Santoro, A, Citterio, G, Pressiani, T, Gregorc, V, Rimassa, L, De Braud, F.G, Rossoni, G, Cappio, F. Caligaris, Lambiase, A, Bordignon, C

Volltext

1228 Phase I study of NGR-hTNF, a vascular targeting agent (VTA), in combination withcisplatin in refractory patients (pts) with solid tumours von Citterio, G, De Braud, F.G, Gregorc, V, De Pas, T.M, Noberasco, C, Boselli, S, Giovannini, M, Cappio, F. Caligaris, Lambiase, A, Bordignon, C

Volltext

Do differences in delivery room intubation explain different rates of bronchopulmonary dysplasia between hospitals? von Gagliardi, Luigi, Bellù, Roberto, Lista, Gianluca, Zanini, Rinaldo

Volltext

Phase II study of NGR-hTNF plus doxorubicin in relapsed ovarian cancer (OC) von Scambia, G., Lorusso, D., Amadio, G., Trivellizzi, N., Pietragalla, A., De Vincenzo, R., Salutari, V., Di Stefano, M., Mangili, G., Montoli, S., Citterio, G., Lambiase, A., Bordignon, C.

Volltext

NGR-hTNF in previously treated patients with malignant pleural mesothelioma (MPM) von De Vincenzo, F., Rossoni, G., Santoro, A., Gregorc, V., Zucali, P. A., Citterio, G., Simonelli, M., Petrella, G., Caligaris-Cappio, F., Lambiase, A., Bordignon, C.

Volltext

Necrotising Enterocolitis in Very Low Birth Weight Infants in Italy: Incidence and Non‐nutritional Risk Factors von Gagliardi, Luigi, Bellù, Roberto, Cardilli, Viviana, De Curtis, Mario

Volltext

Predictive potential of angiogenic plasma biomarkers (PBs) in phase I trial with NGR-hTNF von Rossoni, G., Gregorc, V., Citterio, G., Spreafico, A., Donadoni, G., Vitali, G., Borri, A., Caligaris-Cappio, F., Lambiase, A., Bordignon, C.

Volltext

Bronchopulmonary dysplasia and brain white matter damage in the preterm infant: a complex relationship von Gagliardi, Luigi, Bellù, Roberto, Zanini, Rinaldo, Dammann, Olaf

Volltext

Plasma nitrate plus nitrite changes during continuous intravenous infusion interleukin 2 von CITTERIO, G, PELLEGATTA, F, DI LUCCA, G, FRAGASSO, G, SCAGLIETTI, U, PINI, D, FORTIS, C, TRESOLDI, M, RUGARLI, C

Volltext

Phase II study of NGR-hTNF, a selective vascular targeting agent (VTA), in previously treated patients with hepatocellular carcinoma (HCC) von Santoro, A., Citterio, G., Pressiani, T., De Braud, F. G., Gregorc, V., Rossoni, G., Donadoni, G., Caligaris-Cappio, F., Lambiase, A., Bordignon, C.

Volltext

Increased interleukin-10 serum levels in patients with solid tumours von Fortis, Claudio, Foppoli, Marco, Gianotti, Luca, Galli, Laura, Citterio, Giovanni, Consogno, Giuseppe, Gentilini, Oreste, Braga, Marco

Volltext

Phase Ib study of NGR-hTNF, a selective vascular targeting agent (VTA), in combination with cisplatin in patients with refractory solid tumors von Citterio, G., De Braud, F. G., Gregorc, V., De Pas, T. M., Scalamogna, R., Boselli, S., Giovannini, M., Caligaris-Cappio, F., Lambiase, A., Bordignon, C.

Volltext